Anaptysbio (ANAB) FCF Margin (2016 - 2026)
Anaptysbio's (ANAB) quarterly FCF Margin came in at 101.49% in Q1 2026, down 6292.0% YoY from 1.64% in Q1 2025, and down 177.74% on a QoQ basis from 130.55% in Q4 2025.
Anaptysbio (ANAB) FCF Margin (2016 - 2026) Analysis & Trends
Anaptysbio (ANAB) has 11 years of FCF Margin data on file, last reported at 101.49% in Q1 2026.
- Quarterly FCF Margin fell 6292.0% year-over-year to 101.49% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.54% (up 14068.0% YoY) and the FY2025 annual result came in at 8.36%, up 15663.0% from the prior year.
- FCF Margin eased to 101.49% in Q1 2026, from 130.55% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 130.55% in Q4 2025 to a low of 2172.06% in Q1 2022.
- A 5-year average of 650.96% and a median of 266.7% in 2024 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 228833 bps in 2022, down 202489 bps in 2022.
- Tracing ANAB's FCF Margin over 5 years: stood at 216.22% in 2022, then sank by 78 bps to 384.55% in 2023, then surged by 31 bps to 266.7% in 2024, then jumped by 149 bps to 130.55% in 2025, then tumbled by 178 bps to 101.49% in 2026.
- The last three FCF Margin figures came in at 101.49% (Q1 2026), 130.55% (Q4 2025), and 54.56% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Anaptysbio | 1.70 Bn | 1.41 Bn | - | -101.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.49% |
| Dec 31, 2025 | 130.55% |
| Sep 30, 2025 | -54.56% |
| Jun 30, 2025 | -181.05% |
| Mar 31, 2025 | -38.57% |
| Dec 31, 2024 | -266.70% |
| Sep 30, 2024 | -66.89% |
| Jun 30, 2024 | -194.65% |
| Mar 31, 2024 | -519.29% |
| Dec 31, 2023 | -384.55% |
| Sep 30, 2023 | -1,104.16% |
| Jun 30, 2023 | -739.86% |
| Mar 31, 2023 | -1,800.80% |
| Dec 31, 2022 | -216.22% |
| Sep 30, 2022 | -1,374.71% |
| Jun 30, 2022 | -1,981.25% |
| Mar 31, 2022 | -2,172.06% |
| Dec 31, 2021 | -2,504.55% |
| Sep 30, 2021 | -29.19% |
| Jun 30, 2021 | 43.64% |